150 related articles for article (PubMed ID: 21777717)
21. Capacity of persons with mental retardation to consent to participate in randomized clinical trials.
Fisher CB; Cea CD; Davidson PW; Fried AL
Am J Psychiatry; 2006 Oct; 163(10):1813-20. PubMed ID: 17012694
[TBL] [Abstract][Full Text] [Related]
22. Ascertaining capacity to consent: a survey of approaches used by psychiatrists.
Shah A; Mukherjee S
Med Sci Law; 2003 Jul; 43(3):231-5. PubMed ID: 12899428
[TBL] [Abstract][Full Text] [Related]
23. A memory and organizational aid improves Alzheimer disease research consent capacity: results of a randomized, controlled trial.
Rubright J; Sankar P; Casarett DJ; Gur R; Xie SX; Karlawish J
Am J Geriatr Psychiatry; 2010 Dec; 18(12):1124-32. PubMed ID: 20808101
[TBL] [Abstract][Full Text] [Related]
24. "A feeling that you're helping": proxy decision making for Alzheimer's research.
Dunn LB; Hoop JG; Misra S; Fisher SR; Roberts LW
Narrat Inq Bioeth; 2011; 1(2):107-22. PubMed ID: 24406656
[TBL] [Abstract][Full Text] [Related]
25. Improving recording of capacity to consent and explanation of medication side effects in a psychiatric service for people with learning disability: audit findings.
Roy A; Jain S; Roy A; Ward F; Richings C; Martin M; Roy M
J Intellect Disabil; 2011 Jun; 15(2):85-92. PubMed ID: 21750211
[TBL] [Abstract][Full Text] [Related]
26. Determining the competency of Alzheimer patients to consent to treatment and research.
Marson DC; Schmitt FA; Ingram KK; Harrell LE
Alzheimer Dis Assoc Disord; 1994; 8 Suppl 4():5-18. PubMed ID: 7695856
[TBL] [Abstract][Full Text] [Related]
27. Clinical interview assessment of financial capacity in older adults with mild cognitive impairment and Alzheimer's disease.
Marson DC; Martin RC; Wadley V; Griffith HR; Snyder S; Goode PS; Kinney FC; Nicholas AP; Steele T; Anderson B; Zamrini E; Raman R; Bartolucci A; Harrell LE
J Am Geriatr Soc; 2009 May; 57(5):806-14. PubMed ID: 19453308
[TBL] [Abstract][Full Text] [Related]
28. Reliability of mental capacity assessments in psychiatric in-patients.
Cairns R; Maddock C; Buchanan A; David AS; Hayward P; Richardson G; Szmukler G; Hotopf M
Br J Psychiatry; 2005 Oct; 187():372-8. PubMed ID: 16199798
[TBL] [Abstract][Full Text] [Related]
29. Multimedia Aided Consent for Alzheimer's Disease Research.
Palmer BW; Harmell AL; Dunn LB; Kim SY; Pinto LL; Golshan S; Jeste DV
Clin Gerontol; 2018; 41(1):20-32. PubMed ID: 29182458
[TBL] [Abstract][Full Text] [Related]
30. Qualitative analysis of the capacity to consent to treatment in patients with a chronic neurodegenerative disease: Alzheimer's disease / Analisi qualitativa sulla capacità a prestare consenso al trattamento in pazienti con malattie cronico degenerative neuropsicoorganiche: Demenza di Alzheimer.
Carabellese F; Felthous AR; La Tegola D; Piazzolla G; Distaso S; Logroscino G; Leo A; Ventriglio A; Catanesi R
Int J Soc Psychiatry; 2018 Feb; 64(1):26-36. PubMed ID: 29183264
[TBL] [Abstract][Full Text] [Related]
31. Validation of the French Version of the MacArthur Competence Assessment Tool for Treatment (MacCAT-T) in a French Sample of Individuals with Schizophrenia: Validation de la version française de l'instrument d'évaluation des compétences MacArthur-traitement (MacCAT-T) dans un échantillon français de personnes souffrant de schizophrénie.
Raffard S; Lebrun C; Laraki Y; Capdevielle D
Can J Psychiatry; 2021 Apr; 66(4):395-405. PubMed ID: 33064578
[TBL] [Abstract][Full Text] [Related]
32. Assessing capacity to consent to treatment with cholinesterase inhibitors in dementia using a specific and standardized version of the MacArthur Competence Assessment Tool (MacCAT-T).
Mueller T; Haberstroh J; Knebel M; Oswald F; Kaspar R; Kemper CJ; Halder-Sinn P; Schroeder J; Pantel J
Int Psychogeriatr; 2017 Feb; 29(2):333-343. PubMed ID: 27825402
[TBL] [Abstract][Full Text] [Related]
33. How proxies make decisions about research for patients with Alzheimer's disease.
Sugarman J; Cain C; Wallace R; Welsh-Bohmer KA
J Am Geriatr Soc; 2001 Aug; 49(8):1110-9. PubMed ID: 11555076
[TBL] [Abstract][Full Text] [Related]
34. Consent in Alzheimer's disease research: risk/benefit factors.
Beattie BL
Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S27-31. PubMed ID: 17469678
[TBL] [Abstract][Full Text] [Related]
35. Reliability of clinical judgment of patients' competency to give informed consent: a case vignette study.
Kitamura T; Kitamura F
Psychiatry Clin Neurosci; 2000 Apr; 54(2):245-7. PubMed ID: 10803822
[TBL] [Abstract][Full Text] [Related]
36. Informed consent for Alzheimer's disease clinical trials: a survey of clinical investigators.
Karlawish JH; Knopman D; Clark CM; Morris JC; Marson D; Whitehouse PJ; Kawas CH
IRB; 2002; 24(5):1-5. PubMed ID: 12737167
[No Abstract] [Full Text] [Related]
37. Research on persons with impaired decision making and the public trust.
Michels R
Am J Psychiatry; 2004 May; 161(5):777-9. PubMed ID: 15121640
[No Abstract] [Full Text] [Related]
38. The Paradox of Consent for Capacity Assessments.
Koch P
J Law Med Ethics; 2019 Dec; 47(4):751-757. PubMed ID: 31957575
[TBL] [Abstract][Full Text] [Related]
39. Informed consent and ethical reporting of research in clinical trials involving participants with psychotic disorders.
Weissinger GM; Ulrich CM
Contemp Clin Trials; 2019 Sep; 84():105795. PubMed ID: 31247285
[TBL] [Abstract][Full Text] [Related]
40. A pragmatist's guide to the assessment of decision-making capacity.
Zhong R; Sisti DA; Karlawish JH
Br J Psychiatry; 2019 Apr; 214(4):183-185. PubMed ID: 30896380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
